Company intelligence / Profile preview
Theratechnologies Inc.
Montreal, Quebec, Canadatheratech.gcs-web.com ↗
- Ownership
- Public · THTX
- Employees
- ~103
- Development stage
- Commercial
01
Overview
Theratechnologies has two commercialized products in the US—Trogarzo, a monoclonal antibody for multidrug-resistant HIV, and EGRIFTA SV, a growth hormone-releasing factor analog for reducing excess abdominal fat in people with HIV-associated lipodystrophy. The company’s pipeline includes new formulations of these drugs as well as peptide-drug conjugates in early clinical development targeting oncology indications such as triple-negative breast cancer and ovarian cancer. The company leverages proprietary peptide stabilization technology to enhance drug properties.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Peptide-based drugsMonoclonal antibodies (mAbs)Peptide-drug conjugates (PDCs)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $155.9M
- Total revenue
- $17.7M
- Enterprise value
- $189.6M
Beyond the preview
Go deeper on Theratechnologies Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theratechnologies Inc..